EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Adjunctive Therapies in Periodontitis: Current Concepts and the Future

Rafael Scaf de Molon iD, Joao Paulo Steffens iD, Erica Dorigatti de Avila iD, Wim Teughels iD, Thomas E Van Dyke iD

Journal of Periodontal Research · 2026-02 · 61 (2) · 138-164

DOI: 10.1111/jre.70060 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Periodontal Research, online erschienen am 20.01.2026. Verfasst von Rafael Scaf de Molon und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic and Surgery, School of Dentistry, São Paulo State University (UNESP), São Paulo, Brazil. Hauptthemen laut MEDLINE: Periodontitis. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 207 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Periodontitis is a chronic, host‐mediated inflammatory disease in which microbial dysbiosis and dysregulated immune responses drive the destruction of tooth‐supporting tissues. Although conventional therapy remains centered on mechanical biofilm control, persistent inflammation and alveolar bone loss in susceptible individuals underscore the need for adjunctive strategies. Translating preclinical discoveries into predictable clinical outcomes, however, remains a major challenge in periodontal research. This narrative review integrates two interrelated themes, translational research methodology and adjunctive therapeutic innovation, to critically examine how preclinical findings can be more effectively bridged to clinical practice in periodontitis management. Evidence was synthesized from experimental, translational, and clinical studies retrieved from PubMed, Scopus, and Web of Science up to September 2025. Emphasis was placed on mechanistic insights, model validity, and translational feasibility across host‐modulatory, natural, probiotic, and device‐based adjuncts. Animal models remain indispensable for mechanistic understanding and therapeutic testing but face biological and methodological limitations that hinder direct extrapolation to humans. Interspecies differences, short disease kinetics, and non‐standardized endpoints constrain translational predictability. Addressing these gaps requires refined modeling, standardized outcomes, and integration of systemic risk factors. Within this methodological framework, several adjunctive modalities, including specialized pro‐resolving mediators, probiotics, natural compounds such as curcumin and resveratrol, and device‐based therapies like antimicrobial photodynamic therapy demonstrate promising anti‐inflammatory, osteoimmunomodulatory, and regenerative effects. Emerging translational tools such as bioresponsive drug delivery systems, nanocarriers, 3D‐printed scaffolds, and AI‐driven precision periodontics may further enhance clinical relevance and patient‐specific targeting. Advancing adjunctive periodontal therapy demands harmonized translational models, bioresponsive delivery platforms, and precision diagnostic tools that bridge preclinical efficacy with real‐world outcomes. By aligning methodological rigor with therapeutic innovation, translational research can accelerate the safe and effective clinical integration of next‐generation adjunctive treatments in periodontitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PeriodontitisHumansAnimalsProbioticsPhotochemotherapyTranslational Research, BiomedicalResveratrolSpecialized Pro-Resolving MediatorsCurcuminCombined Modality Therapy

Stichwörter der Autor:innen

adjunctive therapieshost modulationinflammation resolutionnatural compoundsperiodontitisphotodynamic therapyprobioticstranslational research

Substanzen

ResveratrolCurcumin

Autor:innen und Institutionen

  • Department of Diagnostic and Surgery, School of Dentistry, São Paulo State University (UNESP), São Paulo, Brazil.
  • Department of Stomatology, Universidade Federal Do Paraná (UFPR), Paraná, Brazil.
  • Department of Oral Health Sciences, KU Leuven and Dentistry (Periodontology), University Hospitals Leuven, Leuven, Belgium.
  • Department of Periodontology, Faculty of Dentistry, Chulalongkorn University, Bangkok, Thailand.
  • Department of Restorative Dentistry, Faculty of Dentistry, University Malaya, Kuala Lumpur, Malaysia.
  • Center for Clinical and Translational Research, ADA Forsyth Institute, Somerville, Massachusetts, USA.

ORCID-Profile: Rafael Scaf de Molon, Joao Paulo Steffens, Erica Dorigatti de Avila, Wim Teughels, Thomas E Van Dyke

Förderung

  • Fundação de Amparo à Pesquisa do Estado de São Paulo

Zitieren

APA

de Molon, R. S., Steffens, J. P., de Avila, E. D., Teughels, W., & Van Dyke, T. E. (2026). Adjunctive Therapies in Periodontitis: Current Concepts and the Future. Journal of Periodontal Research, 61(2), 138-164. https://doi.org/10.1111/jre.70060

Vancouver

de Molon RS, Steffens JP, de Avila ED, Teughels W, Van Dyke TE. Adjunctive Therapies in Periodontitis: Current Concepts and the Future. Journal of Periodontal Research. 2026;61(2):138-164. doi:10.1111/jre.70060

BibTeX
@article{deMolon2026,
  author = {de Molon, Rafael Scaf and Steffens, Joao Paulo and de Avila, Erica Dorigatti and Teughels, Wim and Van Dyke, Thomas E},
  title = {Adjunctive Therapies in Periodontitis: Current Concepts and the Future},
  journal = {Journal of Periodontal Research},
  year = {2026},
  volume = {61},
  number = {2},
  pages = {138--164},
  doi = {10.1111/jre.70060}
}
Kostenlos starten →